Cytokinetics Provides Update on Cardiac Myosin Inhibitor Programs and Plans to Build a Specialty Cardiology Franchise at Virtual Investor & Analyst Day

New Long-Term Data from FOREST-HCM, the Open-Label Extension Study of Aficamten,Show Sustained Improvements in Clinical Efficacy Endpointsand No Treatment Interruptions for Low Ejection Fraction ...

Related Keywords

San Francisco ,California ,United States ,China ,Theodore Abraham ,Roberti Blum ,Diane Weiser ,Cytokinetics Incorporated Nasdaq ,Symphony Health ,Linkedin ,Youtube ,School Of Cardiovascular Metabolic Health ,Division Of Cardiology ,Adult Cardiac Echocardiography Laboratory ,Development Program For Aficamten ,Globenewswire Inc ,Cardiovascular Genetics Center ,Us Food Drug Administration ,Clinical Trials Program ,Facebook ,Market Research ,Corporate Communications ,Journal Of The American College Cardiology ,Cytokinetics Incorporated ,Exchange Commission ,Clinical Research ,Research Evaluation Of Sustained Treatment ,Harvard Medical School ,National Medical Products Administration ,New Long Term Data ,Open Label Extension Study ,Sustained Improvements ,Clinical Efficacy ,Low Ejection ,Readiness Activities Leverage Insights ,Inform Market Segmentation ,Patient Centric Strategies ,Pre Clinical Data ,Improved Diastolic Function ,Reduced Cardiac Fibrosis ,Animal Model ,Analyst Day ,Research Evaluation ,Sustained Treatment ,Cytokinetic President ,Chief Executive ,Long Term Data ,Development Program ,Commercial Readiness ,Potential Approval ,Potential Treatment ,Meyer Friedman Distinguished Professor ,Cardiac Echocardiography ,Clinical Senior Lecturer ,Metabolic Health ,Associate Professor ,Medical Director ,Cardiovascular Genetics ,Broad Phase ,Quantitative Understanding ,Obstruction Impact ,Exercise Capacity ,Assessment Comparing Aficamten ,Cardiac Endpoints In Adults ,Breakthrough Therapy Designation ,Drug Administration ,Medical Products Administration ,Private Securities Litigation Reform Act ,Safe Harbor ,Vice President ,Heart Failure ,Claims Data ,Clinically Diagnosed Hypertrophic Cardiomyopathy ,American Heart Association Task Force ,American College ,Markets ,